Skip to main content
. 2022 Aug 29;11(9):1166. doi: 10.3390/antibiotics11091166

Table 1.

Population characteristics at ICU admission.

All Patients
n = 135
Day-60 Survivors
n = 89
Day-60 Decedents
n = 46
p
Demographics and comorbidities
Age, years 62.7 (51.6–71.2) 58.3 (49.2–66.1) 71.1 (62.3–75.9) <0.01
Female gender 43 (31.9) 30 (33.7) 13 (28.3) 0.52
Body Mass Index 29 (25.8–34) 29.6 (26.3–34) 28.6 (24.3–31.2) 0.09
Diabetes 40 (29.6) 17 (19.1) 23 (50) <0.01
Chronic diseases (Knaus ≥ 1) 60 (44.4) 36 (40.4) 24 (52.2) 0.19
Immunodepression 16 (11.9) 5 (5.6) 11 (23.9) <0.01
Characteristics at ICU admission
SAPS II 27 (21–39) 25 (18–34) 34 (26–48) <0.01
Time from 1st symptoms to ICU admission, days 9 (7–12) 9 (7–12) 8 (7–15) 0.80
Respiratory SOFA 3 (1–4) 3 (1–4) 3 (2–4) 0.50
Extra-respiratory SOFA 1 (0–4) 1 (0–3) 1 (1–6) <0.01
Ventilatory status at day 1 0.25
None 27 (20) 19 (21.3) 8 (17.4) .
NIV/HFNC/CPAP 78 (57.8) 54 (60.7) 24 (52.2) .
IMV/ECMO 30 (22.2) 16 (18) 14 (30.4) .
Steroid therapy at day 1 127 (94.1) 85 (95.5) 42 (91.3) 0.44
Laboratory data
MR-proADM, nmol/L
Day 1 1 (0.7–1.6) 0.8 (0.7–1.1) 1.4 (1.1–2.7) <0.01
Day 3 0.9 (0.7–1.7) 0.9 (0.7–1.2) 1.5 (0.9–3.6) <0.01
Day 7 1 (0.7–1.9) 0.9 (0.6–1.2) 1.4 (1–3.6) <0.01
IL-6 at day 1, pg/mL 36.3 (9–88) 29.4 (7.6–72) 58.3 (13.2–168) 0.11
CRP at day 1, mg/L 127 (68–177) 129 (57–177) 123.5 (93–172) 0.40
Procalcitonin at day 1, μg/L 0.3 (0.1–1.4) 0.2 (0.1–1) 0.6 (0.3–2) <0.01
LDH at day 1, UI/L 439 (337–573) 427 (335.5–550) 474 (362–632) 0.16
Lymphocytes at day 1, G/L 0.97 (0.59–1.32) 1.01 (0.63–1.39) 0.85 (0.46–1.12) 0.04
D-dimers at day 1, μg/L 916 (556–1768) 811 (537–1431) 1161 (667–2594) 0.07
Ferritin at day 1, μg/L 851 (397–1668) 804 (344–1448) 1088 (575–2418) 0.03

Abbreviations: ICU, Intensive care Unit; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment; NIV, Non-invasive ventilation; HFNC, High Flow Nasal Canula; CPAP, Continuous Positive Airway Pressure; IMV, Invasive Mechanical Ventilation; ECMO, Extra-Corporeal Membrane Oxygenation, MR-proADM, Mid-regional proadrenomedullin; CRP, C-reactive protein; LDH, Lactate Dehydrogenase.